Shanghai Yu Ben Biotechnology Co., Ltd.회사는 제품 목록을 제공합니다.

회사 명:Shanghai Yu Ben Biotechnology Co., Ltd.
전화:15502154572
이메일:yuben012@sina.com
국적:China
URL: https://www.chemicalbook.com/ShowSupplierProductsList30592/0.htm
총 제품 수:511
1 2 3 4 5 6

제품 카탈로그

(R)-Metomidate메틸(R)-1-(1-페닐에틸)-1H-이미다졸-5-카르복실레이트61045-91-8C13H14N2O2
Etomidate EP Impurity A3-(1-페닐-에틸)-3H-이미다졸-4-카르복실산3157-27-5C12H12N2O2
Letermovir Impurity917389-29-8C30H30F4N4O4
SCH529074922150-11-6C31H36Cl2N6
RBM0132092597933-17-8C19H24N6O3
SLX-4090913541-47-6C31H25F3N2O4
(S)-Remoxipride Hydrochloride레목시프라이드염산염73220-03-8C16H24BrClN2O3
BOS3182387633-15-8C28H32Cl2N6O3
CNX-13511276105-89-5C30H35N7O3S
GDC-60362417987-45-0C29H32ClF4N7O2
917389-35-6917389-35-6
LeterMovir-008-R917389-34-5C30H30F4N4O4
LeterMovir-013917389-37-8C29H28F4N4O4
2-Propenoic acid, 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-, methyl ester, (2E)-1791412-04-8C30H30F4N4O4
ALW-II-49-71135219-23-6C21H17F3N4O2
ROCK-IN-5692870-25-0C16H11ClFN3OS
LP-471756413605-11-5C19H23NO2S
NLRP3-IN-102641826-39-1C17H14BrFO3
CP-4476971092847-21-6C29H26ClF2N3O2S
BRD4 Inhibitor-202490311-14-1C18H18N2O4S
MPT0B0141215208-59-5C19H17NO4
HCV-IN-311998705-62-6C12H17FN6O3
hMAO-B-IN-41666119-75-0C20H16O2S
HIF-1 inhibitor-4333357-56-5C18H19IN2O2
p38α inhibitor 3260428-69-1C19H20FNO
DC-TEADin022380228-45-3C19H17NO2S
Nampt activator-1701929-65-9C16H17N3O3
(Rac)-Brassinazole224047-41-0C18H18ClN3O
Picotamide4-메톡시-N,N'-비스(3-피리디닐메틸)-1,3-벤젠디카르복사미드32828-81-2C21H20N4O3
PIP-199622795-76-0C27H28N4O3
GSK33590881628830-21-6C29H37ClN6O5
ML67-331443290-89-8C18H17Cl2N5
VK-II-36955371-66-1C26H26N2O5
2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2043019-99-2C29H42N8O2
2(1H)-Pyridinone,4-hydroxy-5-methyl-(9CI)41935-71-1C6H7NO2
Letermovir Impurity6064-14-8C17H14F6N2O3
THAL-SNS-0322139287-33-3C40H52N8O10S2
Gsk484 hydrochloride1652591-81-5C27H32ClN5O3
2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile869882-16-6C10H9Cl2NO2
VH0321448188-62-2C24H32N4O4S
TD-1062250288-69-6C12H11N5O3
Laninamivir203120-17-6C13H22N4O7
dTRIM242170695-14-2C55H68N8O13S2
ASTX6601799328-86-1C30H42FN5O3
DBRD92170679-45-3C40H45N7O10
CA-49481801343-74-7C21H19N7O3
BMS-P51550371-22-6C27H32N6O2
VB-1242230186-18-0C23H23ClN2O4
SG-0942922283-37-0
UPGL000041890169-95-5C25H26N8O2S2
TH342196203-96-8C15H16N2O2
RG 14620티르포스틴RG14620136831-49-7C14H8Cl2N2
ARV-7662750830-09-0C45H54FN7O6
GSK2152743427-26-9C50H59F3N10O6S
BI-28652937327-93-8C23H27N7O2S
TH-Z932260887-09-8C12H22N2O7P2
RN-18431980-38-0C20H16N2O4S
Auten-99 HBr1049780-58-6C17H15BrN2S
INS3-54A18328998-53-4C23H16ClNO2
Loreclezole117857-45-1C10H6Cl3N3
Eprotirome에프로티롬355129-15-6C18H17Br2NO5
EB-3D1839150-63-8C30H36BrN4O2+
UPF10691048371-03-4C17H13NO3
Y060361832671-96-1C16H15BrN2O5S
MSDC-06021133819-87-0C19H17NO5S
ST034307133406-29-8C10H4Cl4O2
Atopaxar Hydrobromide응급실172594-00751475-53-3C29H38FN3O5
NE-100 hydrochlorideN,N-디프로필-2-(4-메톡시-3-(2-페닐에톡시)페닐)에틸아민모노염산염149409-57-4C23H33NO2.HCl
Nomifensine maleate노미펜신말레산염32795-47-4C16H18N2.C4H4O4
NITD-3491473450-62-2C17H20F2N2O
MJN110Cravatt시약1438416-21-7C22H21Cl2N3O4
AF40431181125-92-8C17H21NO5
BYK 191023 dihydrochloride1216722-25-6C14H15ClN4O
Imiquimod Impurity99010-41-0C15H17N3
Olaparib Impurity2415448-60-9C18H16FN3O2
Buspirone Impurity2726492-72-2C34H52N6O5
INDEX NAME NOT YET ASSIGNED2761681-01-8C21H29ClFN5O7
Demethyl Memantine Hydrochloride디메틸메만틴염산염33103-93-4C11H19N
Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride트리시클로[3.3.1.13,7]데칸-1-아민,3,5,7-트리메틸-,염산염15210-60-3C13H24ClN
7-Acetamido-1,3,5-trimethyladamantane15210-64-7C15H25NO
N-Acetyl DeMethyl MeMantineN-아세틸DeMethylMeMantine778-09-6C13H21NO
9H-Purin-2-amine, 6-chloro-9-[(2R)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]-881881-89-6C11H13ClFN5O3
Benzoic acid, 2-hydroxy-, compd. with (2E)-methyl 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-2-propenoate (1:1)1791412-05-9C37H36F4N4O7
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1)917389-30-1C50H48F4N4O12
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-2991059-71-1C29H28F4N4O5
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate864760-28-1C29H31N3O4
C-DIM 12178946-89-9C23H17ClN2
C-215912780-51-9C17H17Cl2N3
AU12351338780-86-1C17H19F3N2O
NS 398123653-11-2C13H18N2O5S
ASP76631190217-35-6C14H14FNO3
BM6351493762-74-5C25H29FN2O
NAcM-OPT2089293-61-6C23H29Cl2N3O
ML402298684-44-3C14H14ClNO2S
A 438079 hydrochloride899431-18-6C13H10Cl3N5
CB-7921220115453-99-1C14H12N2O2
KY1220292168-79-7C14H10N4O3S
BM212146204-42-4C23H25Cl2N3
CGP-53716152459-94-4C23H19N5O
SAR407899923359-38-0C14H16N2O2
FK-3311116686-15-8C15H13F2NO4S
R-100152097938-51-5C20H19ClN6O2
1 2 3 4 5 6
Copyright 2019 © ChemicalBook. All rights reserved